Do you recommend starting SGLT2 inhibitors for patients with a normal creatinine but who have microalbuminuria and are unable to tolerate ACEi or ARBs?

In a patient who cannot tolerate RAAS inhibition with standard-of-care ARB or ACE-I, I still would still consider starting SGL2 in a patient with microalbuminuria.

In a diabetic patient, an SGL2 inhibitor would definitely be indicated, perhaps with an MRA.

The mechanism of benefit in SGL2 is debatab...